Assertio Holdings, Inc. to Host Investor and Business Development Meetings January 9-11, 2023 in San Francisco
14 December 2022 - 06:07AM
Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ:
ASRT), a specialty pharmaceutical company offering differentiated
products to patients, today announced that its executive team will
host one-on-one investor and business development meetings in San
Francisco January 9-11, 2023. The individual meetings will take
place at the same time as the annual JP Morgan Healthcare
Conference.
For more information and to schedule an investor
meeting, please contact Matt Kreps, investor relations for
Assertio, at mkreps@darrowir.com. To arrange a business development
meeting, please contact Vanessa Fox, Vice President, Business
Development and Commercial Analytics for Assertio, at
vfox@assertiotx.com.
About Assertio
Assertio is a specialty pharmaceutical company
offering differentiated products to patients utilizing a
non-personal promotional model. We have built and continue to build
our commercial portfolio by identifying new opportunities within
our existing products as well as acquisitions or licensing of
additional approved products. To learn more visit
www.assertiotx.com.
Investor Contact:
Matt KrepsManaging DirectorDarrow AssociatesM:
214-597-8200mkreps@darrowir.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Nov 2023 to Dec 2023
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Dec 2022 to Dec 2023